Stocks and Investing
Stocks and Investing
Tue, January 31, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Kevin Caliendo Maintained (CAH) at Strong Buy with Increased Target to $91 on, Jan 31st, 2023
Kevin Caliendo of UBS, Maintained "Cardinal Health, Inc." (CAH) at Strong Buy with Increased Target from $78 to $91 on, Jan 31st, 2023.
Kevin has made no other calls on CAH in the last 4 months.
There are 5 other peers that have a rating on CAH. Out of the 5 peers that are also analyzing CAH, 4 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- A.J. Rice of "Credit Suisse" Maintained at Hold with Increased Target to $79 on, Tuesday, November 22nd, 2022
- Ann Hynes of "Mizuho" Maintained at Hold with Increased Target to $74 on, Monday, November 14th, 2022
- Eric Coldwell of "Baird" Maintained at Hold with Increased Target to $82 on, Monday, November 7th, 2022
- Michael Cherny of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $80 on, Friday, November 4th, 2022
This is the rating of the analyst that currently disagrees with Kevin
- Erin Wright of "Morgan Stanley" Maintained at Buy with Increased Target to $86 on, Friday, January 6th, 2023
Contributing Sources